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The utility of pulse wave velocity (PWV) as a surrogate parameter of arterial vessel
damage (AVD) beyond the traditional brachial blood pressure (BP) measurement may
be questioned as changes in BP are often accompanied by the corresponding changes
in PWV. We sought to establish a new way for BP-independent estimation of AVD
with PWV. We retrospectively analyzed data from 507 subjects with at least one
available 24 h ambulatory BP- and pulse wave analysis, performed with Mobil-O-
Graph (I.E.M., Stolberg, Germany). Individual relationship between eaPWV and central
systolic BP (cSBP) was analyzed for every 24 h recording. The analysis revealed linear
relation between eaPWV and cSBP in all subjects, which is described by equation
eaPWV = a∗cSBP + b. We termed “a” as PWVslope and “b” as PWVbaseline.
All available demographic parameters and clinical data were correlated with eaPWV,
PWVslope and PWVbaseline. 108 subjects had repeated 24 h recordings. Mean age
was 60.7 years and 48.7% were female. 92.5% had hypertension, 22.9% were smoker,
20.5% had diabetes mellitus and 29.6% eGFR < 60 ml/min/1,73 m2. Direct correlation
was observed between age, SBP and eaPWV, while diastolic BP (DBP) and eGFR
correlated inversely with eaPWV. PWVbaseline correlated directly with age and inversely
with DBP, while PWVslope didn’t correlate with any inputted parameter. Using simple
mathematical approach by plotting eaPWV and cSBP values obtained during ABPM, it
is possible to visualize unique course of individual PWV related to BP. Using PWVslope
and PWVbaseline as novel parameters could be a feasible way to approach BP-
independent PWV, though their clinical relevance should be tested in future studies.
Our data underline the importance of BP-independent expression of PWV, when we use
it as a clinical surrogate parameter for the vascular damage.
Keywords: aortic pulse wave velocity, vascular damage, non-invasive oscillometric measurement, vascular
stiffness, arteriosclerosis
INTRODUCTION
Aortic stiffness (AS) is considered to be associated with increased cardiovascular risk. Thus,
European Society of Hypertension recommends screening for elevated AS in hypertension (Mancia
et al., 2013). Pulse wave velocity (PWV) and in particular carotid-femoral PWV (cfPWV) is an
established non-invasive standard to assess AS (Van Bortel et al., 2012). It has been shown to be
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associated with increased cardiovascular mortality and morbidity
independent from established cardiovascular risk factors (Ben-
Shlomo et al., 2014). One of the main problems about establishing
PWV as an independent surrogate parameter for arterial vessel
damage (AVD) is its physiological intrinsic relationship to blood
pressure (BP) level. Higher BP results in a stiffer artery and
higher PWV, yet without any change in anatomical structure
and physiologic properties of the vessel wall. In contrast, AS
represents persistent structural changes in arterial vessel walls.
It is thus matter of discussion whether increased PWV reflects
persistent damage of the arterial wall or is an expression of
elevated BP. Establishment of BP-independent PWV would
probably better reflect real vessel damage.
Emerging non-invasive oscillometric devices use
mathematical approaches and are able to deliver an estimated
aortic PWV (eaPWV) based on pulse wave analysis and wave
separation analysis, whereby major clinical determinants are age,
central systolic BP (cSBP) of the patient and aortic characteristic
impedance (Wassertheurer et al., 2008). Validation studies have
shown this eaPWV be in good correlation with non-invasively
determined cfPWV and invasively determined aortic PWV
(Weber et al., 2015; Reshetnik et al., 2017). eaPWV role as a
predictor of cardiovascular and all-cause mortality has been
shown recently (Sarafidis et al., 2017). Such devices allow easy
and quick calculation of eaPWV (Reshetnik et al., 2017), which
can be repeated plenty of times under varying BP and patient
position. In the present retrospective study we sought to establish
new BP-independent PWV using mathematic analysis of the
repeated eaPWV measurements during 24 h ambulatory BP
and pulse wave monitoring. We hypothesized that establishing
of BP-independent PWV would be first step on the way to
demonstrate real vascular damage.
MATERIALS AND METHODS
All included subjects received long-term (24 h) ambulatory BP
and pulse wave monitoring as a part of clinical routine in
our Department of Nephrology at Campus Benjamin Franklin,
Charité University Berlin. Charité University Berlin review
board approved the study (EA4/112/18). No informed consent
was required for the study purpose. We screened all available
recordings from our database, which comprised time period
from August 2012 to February 2018, and included all subjects
with at least one representative 24 h recording of peripheral BP,
central BP and PWV. All available demographic and clinical data
were collected. Smoker status was missing in 50%, exact protein-
creatinine ratio in 64% and albumin-creatinine ratio in 65% of
study subjects. Other demographic and clinical parameters were
completely present in all subjects. We could analyze 648 long-
term BP and pulse wave analysis recordings from 507 patients
with 43,567 single measurements. Available demographic and
clinical data were summarized and analyzed. For the purpose
of the study “hypertension” was defined, when the diagnosis
“hypertension” has been mentioned in the medical record,
subject had antihypertensive medication or the BP level was
higher than 130/80 mmHg in the ambulatory BP monitoring. Due
to retrospective study design the diagnosis “hyperliproteinemia”
and smoking status were based on data from the medical
record. All implemented procedures were in accordance with
institutional guidelines.
BP-Monitoring and Pulse Wave Analysis
All recordings were performed with Mobil-O-Graph (I.E.M.,
Stolberg, Germany) and data analysis was performed with
HMS Client Software, Version 5.1. The Mobil-O-Graph is a
non-invasive oscillometric device, which combines ambulatory
blood pressure monitoring with long-term pulse wave analysis
(Supplementary Figure 1). The cuff was applied at the left or
right upper arm after the circumference of the arm was measured
and appropriate cuff size was chosen (size 1: 24–34 cm or size
2: 32–42 cm). First, brachial SBP and diastolic BP (DBP) were
obtained. Thereafter, the cuff was again inflated maintaining
the diastolic pressure level for 10 s for assessment of the pulse
waveform using high fidelity pressure sensor. The mathematic
method for pulse wave analysis in Mobil-O-Graph is based on
the algorithm used in ARCSolver (Wassertheurer et al., 2008).
Using generalized transfer functions (Fourier analysis and de-
compensation into wave harmonics) aortic pressure waveform
can be modulated. Central flow curve can be calculated by the
means of an adopted, multi-dimensional Windkessel model. The
time-lag between pressure and flow curve is generally referred
to as “characteristic impedance (Zc),” in which the flow curve
follows the pressure curve. Zc, together with the input variables
of central systolic and diastolic blood pressure and age allows
the device the estimation of aortic PWV (Wassertheurer et al.,
2010). Single recordings were done every 20 min during the day
(0600–2,200 h) and every 30 min during the night (2,200–0600
h). A 24 h recording with ≥ 80% valid single measurements of
SBP, DBP, central BP and PWV was considered representative.
For each parameter of a single 24 h recording, mean value of
all valid single measurements was obtained and included in the
statistical analysis.
Correlation Between Central SBP and
eaPWV
In order to assess the course of eaPWV depending on change
in BP, we used scatter plots to visualize a possible correlation.
All single measurements of cSBP and corresponding eaPWV
from each of the 648 24-h readings were included in separate
scatter plots. The relationship between cSBP and eaPWV
was linear and could be described with following equation:
eaPWV = a∗cSBP + b. We termed factor “a” as “PWVslope”
and factor “b” as “PWVbaseline.” Figure 1 presents scatter
plots with appropriate equations for three individuals from
different age ranges.
Correlation Between Available
Demographic and Clinical Data and
eaPWV, PWVslope, and PWVbaseline
We tested the impact of each available demographic and clinical
parameter on eaPWV, PWVslope, and PWVbaseline using
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FIGURE 1 | Correlation between central blood pressure and pulse wave velocity in individual patients in three different age ranges; A < 25 years; B- 40–50 years;
C > 75 years.
single regression analysis. Those with significant result in single
regression analysis were included in multiple regression analysis.
Repeated Measurements
For a part of the study collective repeated measurements were
recorded. One hundred and eight patients had two recordings.
Twenty five patients had three recordings. Five subjects had
four recordings and one patient had five recordings. Data from
at least one follow up recording were compared to the initial
measurement, respectively. The change of eaPWV, PWVslope,
and PWVbaseline between recordings was assessed and possible
factors impacting this change were evaluated.
Statistics
This study is retrospective. For each continuous variable mean
and standard deviation were calculated. For each dichotomous
variable number of affected subjects and the ratio related to
the whole study collective in per cent were determined. Normal
distribution of parameters was proofed with Kolmogorov-
Smirnov-Test. In order to compare parameters from repeated
measurements paired T-Test was used in case of proven
normal distribution and Wilcoxon paired test in case of non-
normal distribution. A multiple regression approach was used
to determine relationship between available parameters. Two-
sided p-values lower than 0.05 were considered as statistically
significant. Statistic analysis was performed with SPSS Statistics
23.0 (IBM, New York, United States).
RESULTS
Five hundred and seven patients were included in the analysis.
Approximately half of the study collective was female (48.7%).
The mean age was 60.7 [18–92] years and the mean body-mass
index was 27.4 kg/m2. 92.5% of patients had established diagnosis
of hypertension, 33.7% of hyperlipoproteinemia and 22.9% were
smoker. Approximately a fifth had DM (20.5%) and 29.6% have
had chronic kidney disease with an estimated glomerular flow
rate (eGFR) below 60 ml/min/1,73 m2 according to creatinine-
based CKD-EPI equation with the mean protein/creatinine-
ratio of 363 ± 1,025 mg/g and the mean albumin/creatinine-
ratio of 248 ± 792 mg/g. The mean brachial SBP was
133 mmHg and DBP 80 mmHg with the mean heart rate of
69.5 beats/min. The mean cSBP was 121.6 ± 13.4 mmHg and
the mean eaPWV was 9.2 ± 2.2 m/s. The mean PWVslope
was 0.035 with the range from 0.026 to 0.050 m/s∗mmHg
and the mean PWVbaseline was 4.9 with the range from
−0.21 to 11.2 m/s. Further details regarding demographic and
clinical parameters as well as details about medication can be
found in Table 1.
eaPWV and PWVbaseline increased with rising BP and age
(Figures 2, 3). PWVslope increased numerically with increasing
age und SBP. This association was without statistical significance
(Table 2). eaPWV and PWVbaseline were significantly higher in
women compared to men (9.5 ± 2.2 vs. 8.9 ± 2.2, p = 0.001;
and 5.2 ± 2.2 vs. 4.6 ± 2.1 m/s; p < 0.001). No differences in
PWVslope were observed between female and male subjects.
In the single regression analysis we observed statistically
significant correlation between eaPWV and age, SBP, DBP,
mean BP, PP, heart rate, sex, DM, hyperlipoproteinemia, eGFR,
history of hypertension, coronary artery disease, myocardial
infarction, stroke, peripheral arterial disease, medication with
ACE-Inhibitor/Angiotensin receptor blocker, calcium channel
blocker, thiacids, beta blockers and central alpha-agonists.
Multiple regression analysis revealed independent significant
influence of age, SBP, DBP, eGFR and history of myocardial
infarction on the eaPWV. Increased age and SBP were associated
with increasing in eaPWV, while decreased DBP and eGFR
were associated with the rise in eaPWV. Study patients with
history of myocardial infarction had higher eaPWV than
patients without previous myocardial infarction. Using the same
demographic and clinical parameters inputted in single and
multiple regression analyses we showed independent influence of
DBP and age on PWVbaseline (Table 3). In contrast, we observed
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TABLE 1 | Main characteristics and medication of the study collective (n = 507).
Sex
Male, n(%) 260 (51.3)
Female, n(%) 247 (48.7)
Age, years 60.7 ± 16.3
Body mass index, kg/m2 27.4 ± 5.3
Hypertension, n (%) 469 (92.5)
Hyperlipoproteinemia, n (%) 171 (33.7)
Smoker, n (%)∗ 116 (22.9)
Previous stroke, n (%) 26 (5.1)
Coronary heart disease, n (%) 123 (24.3)
Previous myocardial infarction, n (%) 36 (7.1)
Peripheral vascular disease, n (%) 22 (4.3)
Diabetes mellitus, n (%) 104 (20.5)
Chronic kidney disease (eGFR < 60 ml/min/1.73 qm
CKD-EPI-Equation), n (%)
150 (29.6)
eGFR, ml/min/1.73 qm 70.4 ± 26.0
Protein/Creatinin-Ratio, mg/g# 363 ± 1025
Albumin/Creatinin-Ratio, mg/g$ 248 ± 792
ABPM brachial systolic blood pressure, mmHg 133.0 ± 14.8
ABPM brachial diastolic blood pressure, mmHg 80.0 ± 10.7
ABPM mean blood pressure, mmHg 101.2 ± 11.3
ABPM pulse pressure, mmHg 52.9 ± 11.3
ABPM heart rate, beats/min 69.5 ± 10.3
ABPM central systolic blood pressure, mmHg 121.6 ± 13.4
ABPM central diastolic blood pressure, mmHg 81.7 ± 10.9
ABPM estimated aortic pulse wave velocity, m/s 9.2 ± 2.2
ABPM PWVslope, m/s*mmHg 0.035 ± 0.003
ABPM PWVbaseline, m/s 4.9 ± 2.2
Medication
Antiplatelet therapy, n(%) 113 (22.3)
Oral anticoagulation, n(%) 30 (5.9)
Cholesterol reducing therapy, n(%) 180 (35.5)
Statins, n (%) 168 (33.1)
RAAS blocker, n(%) 355 (70)
Calcium-channel blocker, n(%) 275 (54.2)
Aldosterone antagonists, n (%) 37 (7.3)
Thiacid diuretics, n (%) 151 (29.8)
Loop diuretics, n (%) 80 (15.8)
Betareceptor-blocker, n (%) 266 (52.5)
Alphareceptor-blocker, n(%) 63 (12.4)
Central alpha-agonists, n (%) 67 (13.2)
Direct vasodilators, n(%) 15 (3)
*Available in 253 subjects; #available in 181 subjects; $available in 175 subjects.
no statistically significant correlation between any available
demographic and clinical parameter and PWVslope, although it
increased numerically with increasing age and SBP level.
One hundred and eight patients have had repeated recordings.
The mean between-recording time was 4.5 ± 5.8 months.
The mean age of these patients was 60 years and the BMI
was 27.8 kg/m2. 42% were female. The mean eGFR was
72.1 ml/min/1.73 m2 according to creatinine-based CKD-EPI
equation with ca. 29% of the patients having chronic kidney
disease with an eGFR < 60 ml/min/1.73 m2. The mean brachial
FIGURE 2 | Mean estimated aortic pulse wave velocity (eaPWV) values
according to age and blood pressure categories.
BP was 134.9/80.1 mmHg with the mean heart rate of 67.3
beats/min. The mean eaPWV was 9.2 m/s with the mean
PWVslope of 0.035 and PWVbaseline of 4.9 m/s. Supplementary
Table 1 denotes further information about the subgroup of
patients with repeated recordings.
eaPWV was adjusted to the SBP level of 120 mmHg. We
observed statistically significant difference in eaPWV120, while
SBP, DBP, PP and heart rate didn’t change significantly between
recordings (Table 4). We then investigated change in eaPWV120
(delta-eaPWV120) across the range of change in SBP, DBP, heart
rate and PP as well as change in eaPWV120 related to absolute
level of initial SBP, DBP, heart rate and eaPWV120. Increase
in DBP between the measurements was statistically significant
associated with decrease in eaPWV120 (Spearman R2 = 0.048,
p < 0.01). Higher absolute value of initial PP was statistically
significant associated with increase in follow-up eaPWV120
(Spearman R2 = 0.038, p < 0.05). We did not observe any
statistically significant correlation between the change in SBP,
heart rate and PP, absolute level of initial SBP, DBP, heart rate,
eaPWV120 and change in eaPWV120 between the measurements
(Supplementary Figures 2, 3).
DISCUSSION
In our study analysis of the relationship between eaPWV and
cSBP based on multiple single measurements from simultaneous
24 h BP monitoring and pulse wave analysis was essential to
describe individual relationship between PWV and BP.
In 2010, a landmark study was published by Arterial Stiffness’
Collaboration, where reference and normal values for PWV
(measured as cfPWV) were established. The authors observed
a linear relationship between BP and PWV and quadratic
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FIGURE 3 | Mean pulse wave velocity baseline (PWVbaseline) values (right graph) and PWVslope (left graph) according to the age and blood pressure categories.
TABLE 2 | Distribution of estimated aortic pulse wave velocity (eaPWV), PWVslope, and PWVbaseline in the study population according to age and blood
pressure category.
Age category, years systolic blood pressure category, mmHg
<100 100–119 120–139 140–159 160–180 >180
eaPWV as mean ± standard deviation, m/s
<30 5.0 ± 0.1 5.7 ± 0.8 6.0 ± 0.2
30–39 5.5 ± 0.2 5.9 ± 0.2 6.4 ± 0.2 7.2*
40–49 6.3 ± 0.3 6.9 ± 0.4 7.3 ± 0.4 8.3 ± 0.2
50–59 6.3* 7.3 ± 0.4 7.9 ± 0.4 8.4 ± 0.4 8.8 ± 0.2
60–69 8.9 ± 0.5 9.2 ± 0.5 9.9 ± 0.6 10.8 ± 0.4 11.2*
≥70 9.7* 10.7 ± 0.9 11.5 ± 1.0 11.8 ± 0.8 11.9 ± 1.3 14.1*
PWVslope as mean ± standard deviation
< 30 0.034 ± 0.002 0.035 ± 0.004 0.037 ± 0.005
30–39 0.035 ± 0.003 0.035 ± 0.002 0.033 ± 0.004 0.039*
40–49 0.034 ± 0.003 0.035 ± 0.003 0.034 ± 0.003 0.037 ± 0.002
50–59 0.035* 0.034 ± 0.001 0.034 ± 0.002 0.035 ± 0.002 0.037 ± 0.003
60–69 0.033 ± 0.001 0.034 ± 0.003 0.035 ± 0.003 0.034 ± 0.004 0.036*
≥70 0.033* 0.034 ± 0.002 0.035 ± 0.002 0.036 ± 0.004 0.040 ± 0.007 0.037*
PWVbaseline as mean ± standard deviation, m/s
<30 1.4 ± 0.3 1.4 ± 0.9 0.9 ± 0.6
30–39 1.7 ± 0.2 1.8 ± 0.3 1.9 ± 0.6 1.3*
40–49 2.7 ± 0.4 2.7 ± 0.4 2.5 ± 0.6 2.5 ± 0.2
50–59 3.1* 3.8 ± 0.5 3.8 ± 0.5 3.7 ± 0.5 3.1 ± 0.8
60–69 5.5 ± 0.5 5.2 ± 0.6 5.1 ± 0.5 5.7 ± 1.0 4.9*
≥ 70 6.7* 7.2 ± 0.9 7.4 ± 1.0 7.1 ± 1.0 5.9 ± 0.8 7.7*
*Standard deviation not available.
relationship between PWV and age (Reference Values for
Arterial Stiffness’ Collaboration, 2010). The strength of the
study was that all PWV values were measured. However,
only few single measurements per patient were obtained and
detection of individual relationship between PWV values and
corresponding BP level was not possible. Analysis of over
11,000 patients allowed to draw general conclusions about
PWV course with change in age and BP in whole study
collective. However, individual impact of BP-level on PWV in
single patients could not be determined. This point represents
a current dilemma in interpreting PWV as an additional
cardiovascular risk marker.
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TABLE 3 | Significant influence parameters on estimated aortic pulse wave
velocity (eaPWV) and PWVbaseline in multiple regression analysis.
Dependent parameter: eaPWV
Independent parameter Regression coefficient R2-value p-value
Age 0.13 0.86 <0.001
Systolic blood pressure 0.03 0.05 0.007
eGFR 0.002 0.0007 0.02
Myocardial infarction 0.21 0.0006 0.02
Dependent parameter: PWVbaseline
Age 0.12 0.88 <0.001
Diastolic blood pressure -0.018 0.007 <0.001
TABLE 4 | Comparison between initial and follow-up recording (n = 108).
Initial recording Follow up recording p-value
Systolic blood
pressure, mmHg
134.4 ± 14.3 135.6 ± 15.6 0.35#
Diastolic blood
pressure, mmHg
80.0 ± 10.7 80.5 ± 11.6 0.59#
Pulse pressure,
mmHg
54.4 ± 11.3 55.2 ± 11.3 0.34*
Heart rate,
beats/min
67.8 ± 9.7 67.4 ± 10.5 0.57#
PWV120, m/s 8.9 ± 2.1 9.0 ± 2.1 <0.001#
PWVslope 0.0347 ± 0.00297 0.03495 ± 0.00324 0.37#
PWVbaseline, m/s 4.79 ± 2.11 4.81 ± 2.08 0.56#
eaPWV120- estimated aortic pulse wave velocity for the systolic blood
pressure of 120 mmHg according following equation: PWV120 = 120
mmHg*PWVslope + PWVbaseline; #paired t-test; *paired Wilcoxon-test.
In our study, we used a device, which is able to estimate
aortic PWV using oscillometric approach. Currently required
parameters for the eaPWV calculation are age, measured brachial
BP and data from pulse wave analysis (Wassertheurer et al.,
2008). Approaching the dilemma of the BP-independent PWV
we analyzed individual relationship between eaPWV and SBP
based on the data coming from ABPM. Based on our findings
the relationship can be described with an individual linear
equation. According to determined equation PWVslope could
represent individual reaction of PWV to an increase in BP,
while PWVbaseline could probably reflect baseline status of the
arterial vessels. Though we observed increasing PWVslope values
with increasing age and BP, this association was not statistically
significant. Additionally, we did not show association between
PWVslope and any other clinical parameter. Thus, the clinical
relevance of the PWVslope as a separate parameter is still to be
proofed. A possible explanation could be a high impact of age
in the determination of the eaPWV in the algorithm. Recently,
the clinical relevance of the eaPWV beyond the impact of age
and SBP has been questioned (Schwartz et al., 2019). Despite
the known shot-cuts of the oszillometric PWV estimation this
method is valid, feasible and easy to apply in the clinical practice.
It is able to capture multiple PWV changes with corresponding
changes in BP. Previously to the era of oszillometric PWV
measurement multiple PWV recordings were sophisticated and
such relationships as obtained in our study could not be
established. Based on the mathematical analysis of derived data
we were able to reach a “standardization” of the PWV using novel
parameters PWVbaseline und PWVslope and in such a way to
separate the BP-impact on it. The standardization to a particular
BP level is also useful to compare PWV between the patients but
also to compare PWV values in the same individual over a time
course as we have done in a part of our study collective with
available repeated measurements.
To our knowledge, this is the first time serial BP and
corresponding PWV changes have been reported. Greve et al.
(2016) assessed the performance of estimated PWV, calculated
from age, mean arterial pressure, using equations published
by Arterial Stiffness’ Collaboration. Though estimated PWV
performed well in healthy subjects, it did not add any predictive
value in patients with diabetes mellitus or on antihypertensive
drugs. As mentioned above, this might be due to high individual
variability, which cannot be addressed by using equations
coming from another study collective (Greve et al., 2017). Lim
et al. (2015) observed intraindividually increasing cfPWV with
increasing mean BP in healthy subjects. However, they did not
describe individual relationship between cfPWV and BP in their
study collective.
The relation between cSBP and eaPWV can readily be
translated to the relation between obtained brachial SBP and
eaPWV, as we observed well known strong correlation between
SBP and cSBP in our data (Pearson correlation coefficient 0.96).
We choose cSBP as an independent variable based on the original
publication of the method, where authors described cSBP as
one of the major determinants needed for the calculation of the
eaPWV (Hametner et al., 2013).
We observed well-known association between eaPWV with
age and SBP. As in the study published 2010 by Arterial
Stiffness’ Collaboration (Reference Values for Arterial Stiffness’
Collaboration, 2010) the correlation between eaPWV and SBP
was linear and the correlation between eaPWV and age was
better explained by quadratic equation. Furthermore, we saw
significant increase in eaPWV with a decreasing kidney function
and decreasing DBP. The influence of age, SBP and chronic
kidney disease on AS and PWV is well known and could
be demonstrated in previous studies (Tolle et al., 2015). The
impact of DM on AS (De Angelis et al., 2004) and PWV
(Cardoso and Salles, 2016) as its surrogate parameter is also well
known. However, we could not show significant independent
influence of DM on eaPWV in our collective. One possible
explanation could be a relatively low prevalence of DM in our
study collective as only circa 20% of patients had DM, which
was non-insulin-dependent in the majority of cases. One can
speculate that changes in vascular structure might have been
only moderate. Furthermore, the impact of BP, age and kidney
function had statistically higher impact on eaPWV compared
to DM in our analysis. Higher prevalence of isolated systolic
hypertension in subjects with DM has been shown previously
(Os et al., 2006). Observed increase in eaPWV with lower DBP
in our study could thus been interpreted as an indirect link
between DM and eaPWV. Supporting this hypothesis, diabetics
showed significantly lower DBP compared to non-diabetics
in our collective.
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Recent data pointed out that changes in heart rate could also
contribute to significant changes in PWV (Tan et al., 2016) and
adjustment of PWV to a heart rate would also be necessary. We
did not see any significant independent effect of heart rate on
PWV in our data.
Many studies demonstrated severe differences in PWV
between female and male subjects (DuPont et al., 2019). We
observed higher eaPWV120 in women. However, we did not
show any independent effect of sex on PWV in multiple
regression analysis. Additionally, women were significantly older
(63.2± 15.9 vs. 58± 16.4 years) than men in our study collective,
which is probably the major reason for higher eaPWV.
Many studies demonstrated significant influence of smoking
on AS (Doonan et al., 2010). We did not observe any significant
independent effect of smoking on eaPWV. This result is, however,
limited as data on smoking status were available in only 50% of
the study subjects due to retrospective study design.
Comparison of repeated ABPM readings, which were
performed on average 4.5 months apart, revealed statistically
significant change in eaPWV120. However, the mean difference
of 0.1 m/s is not relevant from the clinical point of view. We
observed no clinically relevant impact of any hemodynamic
parameter on eaPWV120, no matter whether the amount of
difference between initial and follow up recording or absolute
value of the initial recording were considered (Supplementary
Figures 2, 3), although single variables (e.g., PP) indeed showed
statistically significant impact on change in eaPWV120.
Assuming that remodeling of vessel wall is a very slow process,
the period of 4.5 months is likely to be too short to reveal
a real change in the architecture of the vessel wall explaining
why the individual BP-adjusted eaPWV did not change in
our study. Thus far, published studies compared initial and
follow up PWV-values without individual BP-adjustment. For
instance, 2011 published study by Ignace et al. compared cfPWV
before and after kidney transplantation (Ignace et al., 2011).
Though cfPWV was adjusted to the reduction in mean BP,
individual adjustment to the particular level of BP is missing and
individual degree of BP-impact on cfPWV cannot be obtained.
Whether observed reduction in cfPWV of mean 0.5 m/s 3
months after transplantation in patients still on comparably
high level of immunosuppression really reflects improvement in
AS is debatable.
CONCLUSION
In conclusion, using simple mathematical approach by plotting
eaPWV and cSBP values obtained during ABPM, it is possible to
visualize unique course of individual PWV related to BP. Using
PWVslope and PWVbaseline as novel parameters could be a
feasible way to approach BP-independent PWV, though clinical
relevance should be tested in future studies. Our data underline
the importance of BP-independent expression of PWV, when we
use it as a clinical surrogate parameter for the vascular damage.
We acknowledge several limitations of our study: Attributable
to the oscillometric method, which we used, obtained PWV-
values were not measured but estimated based on pulse wave
analysis and utilization of age and central BP. BP-adjustment
of eaPWV using obtained individual PWVslope could thus
represent the extent of arterial damage. However, the clinical
potential of the obtained novel parameters PWVbaseline and
PWVslope is not yet established and the next necessary
step would be to correlate these parameters to relevant
clinical endpoints.
Worth mentioning is the fact that pulse wave analysis is done
in the brachial artery, which is a muscular artery, used as a
surrogate for PWV in the aorta, which is an elastic vessel. As the
anatomy of elastic and muscular arteries is different, they could
stiffer in distinct manner (Shirwany and Zou, 2010).
Retrospective design of the study precludes inferences about
causal relationships. All available demographic and clinical
parameters were included, however, unidentified confounders
cannot be ruled out. For instance, no information about the
cuff position was available, which is known to be potential
influence factor on the PWV. The study population was limited
to a specific group of non-severe ill subjects, with a majority
having hypertension, mild kidney disease and obesity. Thus,
further studies are needed in other populations to confirm and
generalize our findings. Low prevalence of diabetes mellitus and
advanced kidney disease might have diminished the known effect
of these influence factors on PWV. Small part of the subjects
with repeated measurements and short follow up period could
be a reason for clinically non-relevant change in eaPWV120,
obtained in the study.
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